

Cover Story
Conversation with The Cancer Letter
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
In Brief


Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for April 2025
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature” - Bhattacharya: New grant review criterion is “not political”
- Population-based cancer surveillance is a national treasure at risk
- Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.
- ACOG says it will no longer accept federal funding